Page last updated: 2024-11-05

tropicamide and Myasthenia Gravis

tropicamide has been researched along with Myasthenia Gravis in 1 studies

Tropicamide: One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meyer, D1
Hamilton, RC1
Gimbel, HV1

Other Studies

1 other study available for tropicamide and Myasthenia Gravis

ArticleYear
Myasthenia gravis-like syndrome induced by topical ophthalmic preparations. A case report.
    Journal of clinical neuro-ophthalmology, 1992, Volume: 12, Issue:3

    Topics: Cataract Extraction; Female; Humans; Middle Aged; Myasthenia Gravis; Ophthalmic Solutions; Propoxyca

1992